Month: December 2022

In today’s episode of let’s talk stocks, I am going to share with you more than 8 great advantages of trading options and also calendar spreads. We’ll talk about things like capital, risk, percentage of returns, direction, hedging, flexibility, and much more… #optionscalendars #tradingoptions #calendarspreads #tradingbenefits #hedging ? Video Chapters 00:00 Introduction 01:40 1 –
0 Comments
In this article AJRD TSLA MESA SBGI Follow your favorite stocksCREATE FREE ACCOUNT Check out the companies making headlines before the bell: Aerojet Rocketdyne (AJRD) – Aerojet Rocketdyne agreed to be bought by rival defense contractor L3Harris Technologies (LHX) for $4.7 billion, or $58 per share in cash. Aerojet Rocketdyne rose 2% in the premarket,
0 Comments
In 2023, stock market uncertainties will worsen, rewarding investors who seek cheap dividend stocks. The bigger their discount to their fair value, the more margin of safety the company offers. Companies that pay dividends prioritize cash flow first. Management will allocate cash flow to shareholders, rewarding them with a high dividend yield. Finding cheap dividend
0 Comments
It seems like yesterday that environmentally friendly fuel-cell systems provider FuelCell Energy (NASDAQ:FCEL) was all the rage on Wall Street. Lately, however, FCEL stock has been a money loser for investors. It’s sensible to check FuelCell Energy’s financials carefully – and considering the unfavorable value proposition of the shares now, it’s hard to give them anything
0 Comments
With a good deal of pent-up travel demand, keep an eye on experience stocks. For one, according to SWNSDigital.com, 80% of Americans say they need a vacation in 2023 “more than ever before.” Two, according to Hospitalitynet.org, “The most recent American Travel Sentiment Study indicates that 92% of Americans have travel plans in the next six
0 Comments
Some of the hottest biotech stocks are safe and recession-proof. After all, we can’t stop people from aging – at least, not yet. We can’t stop people from seeking treatments for a myriad of issues. Plus, there’s growing demand for innovation in gene therapies, immune-oncology, precision medicine, machine-learning drug discovery, and treatments for unmet medical
0 Comments
In Richard Koo’s newest book, he provides an interesting comparison between Japan in the 1990’s the the United States today (2015). Koo suggests that America’s use of quantitative easing could potentially have detrimental long-term impacts to the economy because interest rates have been so heavily manipulated. The result could mean higher interest rates on long
0 Comments